Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: a two-year follow-up study

被引:16
作者
Bassotti, G.
D'Onofrio, V.
Battaglia, E.
Fiorella, S.
Dughera, L.
Iaquinto, G.
Mazzocchi, A.
Morelli, A.
Annese, V.
机构
[1] Univ Perugia, Gastroenterol & Hepatol Sect, Dept Clin & Expt Med, I-06100 Perugia, Italy
[2] San Giovanni Moscati Hosp, Gastroenterol & Digest Endoscopy Unit, Avellino, Italy
[3] Cardinal Massaja Hosp, Asti, Italy
[4] IRCCS Hosp, Unit Gastroenterol Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[5] Univ Turin, Dept Gastroenterol & Clin Nutr, I-10124 Turin, Italy
关键词
D O I
10.1111/j.1365-2036.2006.02907.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Treatment of oesophageal achalasia with intrasphincteric injections of botulinum toxin has proved to be a successful alternative treatment modality. However, little is known about its long-term effects in very old patients. Aim To evaluate the effects of such treatment in octo-nonagerians during a 2-year follow-up period. Patients and methods Thirty-three patients with idiopathic oesophageal achalasia (range 81-94 years) entered the study. After basal evaluation and screening procedures, 100 U of botulinum toxin was injected at the lower oesophageal sphincter, and the procedure was repeated 1 month later. Data were collected at baseline and were compared after 1 and 2 years following the procedure. Results Seventy-eight per cent of patients were considered responders at 1 year and 54% were considered responders at 2 years. The weight gain at the end of the follow-up period was 2 (0-3) kg. No significant relationship was found between baseline lower oesophageal sphincter pressure and symptoms score after 1 and 2 years of follow-up; moreover, no major complications of botulinum toxin therapy were reported. Conclusion Treatment of very old achalasic patients with botulinum toxin is safe, effective and yields good quality of life in a substantial proportion of these subjects.
引用
收藏
页码:1615 / 1619
页数:5
相关论文
共 36 条
[1]   Dysphagia in aging [J].
Achem, SR ;
DeVault, KR .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (05) :357-371
[2]   Treatment of achalasia:: Botulinum toxin injection vs. pneumatic balloon dilation.: A prospective study with long-term follow-up [J].
Allescher, HD ;
Storr, M ;
Seige, M ;
Gonzales-Donoso, R ;
Ott, R ;
Born, P ;
Frimberger, E ;
Weigert, N ;
Stier, A ;
Kurjak, M ;
Rösch, T ;
Classen, M .
ENDOSCOPY, 2001, 33 (12) :1007-1017
[3]   Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia [J].
Annese, V ;
Basciani, M ;
Perri, F ;
Lombardi, G ;
Frusciante, V ;
Simone, P ;
Andriulli, A ;
Vantrappen, G .
GASTROENTEROLOGY, 1996, 111 (06) :1418-1424
[4]   Perendoscopic injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilation [J].
Annese, V ;
Basciani, M ;
Lombardi, G ;
Caruso, N ;
Perri, F ;
Simone, P ;
Andriulli, A .
GASTROINTESTINAL ENDOSCOPY, 1996, 44 (04) :461-465
[5]  
Annese V, 1998, MUSCLE NERVE, V21, P1540, DOI 10.1002/(SICI)1097-4598(199811)21:11<1540::AID-MUS27>3.0.CO
[6]  
2-2
[7]   A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia [J].
Annese, V ;
Bassotti, G ;
Coccia, G ;
Dinelli, M ;
D'Onofrio, V ;
Gatto, G ;
Leandro, G ;
Repici, A ;
Testoni, PA ;
Andriulli, A .
GUT, 2000, 46 (05) :597-600
[8]   Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia [J].
Bansal, R ;
Nostrant, TT ;
Scheiman, JM ;
Koshy, S ;
Barnett, JL ;
Elta, GH ;
Chey, WD .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (03) :209-214
[9]   Esophageal dysfunction in scleroderma - Relationship with disease subsets [J].
Bassotti, G ;
Battaglia, E ;
Debernardi, V ;
Germani, U ;
Quiriconi, F ;
Dughera, L ;
Buonafede, G ;
Puiatti, P ;
Morelli, A ;
Spinozzi, F ;
Mioli, PR ;
Emanuelli, G .
ARTHRITIS AND RHEUMATISM, 1997, 40 (12) :2252-2259
[10]  
Bassotti G, 1999, ALIMENT PHARM THERAP, V13, P1391